Use the Back button in your browser to see the other results of your search or to select another record.
|Arthroscopic subchondral drilling followed by injection of peripheral blood stem cells and hyaluronic acid showed improved outcome compared to hyaluronic acid and physiotherapy for massive knee chondral defects: a randomized controlled trial|
|Saw K-Y, Anz AW, Ng RC-S, Jee CS-Y, Low SF, Dorvault C, Johnson KB|
|Arthroscopy 2021 Aug;37(8):2502-2517|
|5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*|
PURPOSE: The purpose of this study was to evaluate the safety and efficacy of intra-articular injections of autologous peripheral blood stem cells (PBSC) plus hyaluronic acid (HA) after arthroscopic subchondral drilling into massive chondral defects of the knee joint and to determine whether PBSC therapy can improve functional outcome and reduce pain of the knee joint better than HA plus physiotherapy. METHODS: This is a dual centre randomized controlled trial (RCT). Sixty-nine patients age 18 to 55 years with International Cartilage Repair Society (ICRS) grade 3 and 4 chondral lesions (size >= 3cm2) of the knee joint were randomized equally into (i) control group receiving intra-articular injections of HA plus physiotherapy and (ii) intervention group receiving arthroscopic subchondral drilling into chondral defects and postoperative intra-articular injections of PBSC plus HA. The co-primary efficacy endpoints were subjective International Knee Documentation Committee (IKDC) and Knee Injury and Osteoarthritis Outcome Score (KOOS)-pain subdomain measured at month 24. The secondary efficacy endpoints included all other KOOS subdomains, numeric rating scale (NRS) and Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scores. RESULTS: At 24 months, the mean IKDC scores for the control and intervention groups were 48.1 and 65.6, respectively (p < 0.0001). The mean for KOOS-pain subdomain scores were 59.0 (control) and 86.0 (intervention) with p < 0.0001. All other KOOS subdomains, NRS and MOCART scores were statistically significant (p < 0.0001) at month 24. Moreover, for the intervention group, 70.8% of subjects had IKDC and KOOS-pain subdomain scores exceeding the minimal clinically important difference (MCID) values, indicating clinical significance. There were no notable adverse events that were unexpected and related to the study drug or procedures. CONCLUSIONS: Arthroscopic marrow stimulation with subchondral drilling into massive chondral defects of the knee joint followed by postoperative intra-articular injections of autologous PBSC plus HA is safe and showed a significant improvement of clinical and radiological scores as compared to HA plus physiotherapy. LEVEL OF EVIDENCE: Level I, RCT.